BioSpace News Archive

BioMidwest

Astellas Oncology Announces C³ Prize® Call for Entries to Award $200,000 to the Best Ideas in Cancer Care Beyond Medicine

Astellas Pharma US, Inc. announced the call for entries for the fourth annual Astellas Oncology C3 Prize, a challenge that funds the best non-treatment ideas to improve cancer care for patients, caregivers and their loved ones.

May 20, 2019
·
6 min read
Business

Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis

Phase 2 Clinical Trial Enrollment Progresses While World Health Organization Provides Generic Name of AG013 Compound

May 20, 2019
·
4 min read
BioCapital

Data from Incyte’s Inflammation and Autoimmunity Portfolio to be Featured at the 24th World Congress of Dermatology

Investor conference call and webcast scheduled for Monday, June 17 at 8 a.m. EDT

May 20, 2019
·
3 min read
Deals

Camber Spine Reports First Quarter 2019 Sales Results

Camber Spine, a leading innovator in spine and medical technologies, reported preliminary unaudited proprietary sales results for the first quarter ending March 31, 2019.

May 20, 2019
·
1 min read
HAMLET Pharma Appoints Issa PR to Launch First Major Clinical Trials for a New Cancer Killing Molecule

The Breakthrough Discovery Using Breast Milk Will Complete in 2019

May 20, 2019
·
4 min read
Business

Safe Kids Worldwide and the Association for the Advancement of Automotive Medicine Collaborate to Prevent Pediatric Vehicular Heatstroke

Experts Agree on the Best Prevention: Technology and Public Education

May 20, 2019
·
4 min read
Biotech Beach

Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases

Reneo Pharmaceuticals announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular metabolism and energy production.

May 20, 2019
·
3 min read
Biotech Beach

Neurocrine Biosciences Presents New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia, Demonstrating the Effect of Involuntary Movements on Patient Quality of Life

Neurocrine Biosciences, Inc. announced new data from RE-KINECT, the largest real-world screening study to date of patients with clinician-confirmed possible tardive dyskinesia, demonstrating the effect of involuntary movements on patient health-related quality of life.

May 20, 2019
·
12 min read
Business

Eisai Inc. Announces the Appointment of Dr. Luca Dezzani as Vice President, U.S. Medical Affairs, Oncology Business Group

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announced the immediate appointment of Dr. Luca Dezzani as Vice President, U.S. Medical Affairs, Oncology Business Group.

May 20, 2019
·
3 min read
Deals

Flexpoint Sensor Systems Announces Q1 2019 Results and Anticipates Significant Purchase Orders Late Second Quarter, Early Third Quarter

Flexpoint Sensor Systems, Inc. announced the company’s financial results for the first quarter ended March 31, 2019.

May 20, 2019
·
5 min read